Recording adverse reactions, allergies and intolerances to medications and other substances is universally regarded as a high priority for clinical safety. This is the ‘Adverse reaction risk’ archetype’s story - an international, cross SDO collaboration that achieved consensus. It demonstrates the potential value that comes if we choose to work together, rather than create more silos.